Article
B-cell maturation agent (BCMA)-targeted chimeric antigen receptor (CAR)-T-cell therapy: toxic but h
Rating:
0.0
Views:
36
Likes:
1
Library:
1
A new meta-analysis finds high rates of efficacy and high rates of toxicity in multiple myeloma patients treated with B-cell maturation agent (BCMA)-targeted chimeric antigen receptor (CAR)- T cells.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value